Mesothelioma

Mesothelioma used to be a rare disease, but because of the widespread use of asbestos it has now been described as an epidemic around the world. There has been an explosion in knowledge about mesothelioma in the past few years, partly stimulated by the formation of the International Mesothelioma Interest Group network. This book represents a state-of-the-art review of the disease, from laboratory through to the bedside, from diagnostic procedures through to treatment and from imaging and early detection through to medico-legal aspects. It will be of interest to any clinician or scientist with any involvement in asbestos-related diseases.


Table of Contents
Contributors
Introduction
1 The North American Experience with Malignant Mesothelioma 1
2 History and Experience of Mesothelioma in Europe 29
3 The History of Mesothelioma in Australia 1945-2001 55
4 Mesothelioma and Exposure to Asbestos in South Africa: 1956-62 87
5 Mesothelioma and Exposure to Asbestos in South Africa: 1962-2000 93
6 Clinical and Palliative Care Aspects of Malignant Mesothelioma 111
7 Pleuroscopy in the Management of Malignant Pleural Mesothelioma 127
8 Pathology of Mesothelioma 143
9 Surgery and Staging of Malignant Mesothelioma 185
10 Imaging in Mesothelioma 201
11 Treatment of Malignant Mesothelioma: Radiotherapy and Chemotherapy 209
12 Gene Therapy for Malignant Mesothelioma - 'Suicide Gene' and Immunological Approaches 223
13 Photodynamic Therapy (PDT) and Pleural Mesothelioma 235
14 Doctors in the Courtroom: Medico-Legal Aspects of Mesothelioma in Australia 253
15 Asbestos Fibres and their Interaction with Mesothelial Cells in vitro and in vivo 273
16 Novel Molecular, Epidemiological, and Therapeutic Issues in Mesothelioma: The Role of SV40 295
17 The Molecular Pathogenesis of Mesothelioma 307
18 Immunotherapy of Malignant Mesothelioma 325
19 Epidemiology of Mesothelioma 339
20 Mesothelioma in Japan 351
Index 359


Credits goes out to: Taylor & Francis, Inc.